Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SEMBullishM&Anews

High materiality8/10

Select Medical completes $3.9B take-private at $16.50/ share

Jun 30, 2026, 4:17 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The offer delivers an explicit premium to pre-announcement levels and VWAP, with near-term price convergence to $16.50; delisting implies no further upside beyond the deal value.

AI summary

What happened, with direct paths to the underlying reporting

Select Medical closes its sale to a consortium led by Ortenzio, Jackson and WCAS for $16.50 per share, valuing the company at about $3.9 billion. The merger closes July 1, 2026, after stockholders approved on June 26, 2026, and the stock will be delisted on completion. Near-term investors should expect the stock to move toward the offer price with limited post-close upside.

Select Medical acquired by a WCAS-led consortium; price $16.50 per share.
Deal values the company at about $3.9 billion; closing July 1, 2026.
Stock will cease trading on NYSE upon merger closing.
Officers Ortenzio and Jackson stay in leadership; stockholders approved June 26, 2026.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Select Medical completes $3.9B take-private at $16.50/ share

Select Medical Agrees to Acquire Valir Rehabilitation Hospital